DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20190276

Association of serum neutrophil gelatinase associated lipocalin (NGAL) levels with preeclampsia

M. Dhivya, Chippy Tess Mathew, G. Jeyachandran

Abstract


Background: Preeclampsia is a systemic disorder that affects multiple organs and is characterized by the new onset of hypertension and proteinuria or end-organ dysfunction or both in the second half of pregnancy. NGAL is a 25-KDa protein of the lipocalin family and is considered to be a novel biomarker for ischemic injury. The objective of this study is to compare the levels of serum NGAL in preeclamptic patients and gestational age matched normotensive controls.

Methods: The study design is case control study in which pregnant women with preeclampsia (n=40) are selected as cases. Cases were selected from pregnant women attending OG-OPD and IP satisfying the inclusion criteria and not coming under exclusion criteria. 0.5ml of blood was collected in vacutainers and was centrifuged at 3500rpm for 10 minutes. The serum thus separated was aliquoted into smaller plain containers and stored at -20 degree Celsius for analysis. The urine sample was also collected. Controls were also selected from the OP patients.

Results: In present study, the serum NGAL ranged from 40-900ng/ml in cases and from 110-795ng/ml in controls. There is no difference in NGAL between cases and control. The correlation coefficients between the NGAL levels and other parameters like maternal age, gestational age, systolic Blood pressure, diastolic Blood pressure, uric acid levels, urine PCR are also not statistically significant.

Conclusions: Serum NGAL levels are not significantly elevated in patients with preeclampsia when compared with the normotensive controls and also there is no significant correlation between serum NGAL levels and other assessed parameters.


Keywords


Neutrophil gelatinase associated lipocalin (NGAL), Preeclampsia, Urine PCR

Full Text:

PDF

References


Lindheimer, Taler SJ, Cunningham. Hypertension in pregnancy. J Am Soc Hypertension. 2010;4:68-78.

American College of Obstetricians and Gynecologists. Diagnosis and management of preeclampsia and eclampsia: ACOG practice bulletin, No. 33. Int J Gynaecol Obstet. 2002;77:67-5.

World Health organization. The World Health report: 2005: make every mother and child count. Geneva: WHO;2005.

Daley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Carribean. Br J Obstet Gynecol. 1992;99:547-3.

Siribamrungwong M, Chinudomwong P. Relation between acute kidney injury and pregnancy-related factors. J Acute Dis. 2016;5(1):22-8.

Patel ML, Sachan R, Gangwar R, Sachan P, Natu SM. Correlation of serum neutrophil gelatinase-associated lipocalin with acute kidney injury in hypertensive disorders of pregnancy. Int J Nephrol Renov Dis. 2013;6:181-6.

Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens. 2008;21(5):521-6.

Machado S, Figueiredo N, Borges A, Pais MS, Freitas L, Moura P, et al. Acute kidney injury in pregnancy: a clinical challenge. J Nephrol. 2012;25(01):19-30.

Xiao J, Niu J, Ye X, Yu Q, Gu Y. Combined biomarkers evaluation for diagnosing kidney injury in preeclampsia. Hypertension pregnancy. 2013;32(4):439-9.

Panidis D, Tziomalos K. The effects of obesity and polycystic ovary syndrome on serum lipocalin-2 levels: a cross-sectional study. Reprod Biol Endocrinol. 2010;8:151.

Lou Y1, Wu C1, Wu M1, Xie C, Ren L. The changes of neutrophil gelatinase-associated lipocalin in plasma and its expression in adipose tissue in pregnant women with gestational diabetes. Diab Res Clin Pract. 2014;104(1):136-42.

D'anna R, Baviera G, Giordano D, Todarello G, Russo S, Recupero S, et al. Neutrophil gelatinaseā€associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. Acta obstet Gynecol Scandinav. 2010;89(2):275-8.

Simonazzi G, Capelli I, Curti A, Comai G, Rizzo N, La Manna G. Serum and urinary neutrophil gelatinase-associated lipocalin monitoring in normal pregnancy versus pregnancies complicated by pre-eclampsia. In Vivo. 2015;29(1):117-21.

Quinones Galvan A, Natali A, Baldi SI, Frascerra SI, Sanna GI, Ciociaro DE, et al. Effect of insulin on uric acid excretion in humans. Am J Physiol Endocrinol Metabol. 1995;268(1):E1-5.

Pereira KN, Knoppka CK, da Silva JE. Association between uric acid and severity of pre-eclampsia. Clin Lab. 2014;60(2):309-14.

Pramanik T, Khatiwada B, Pradhan P. Serum uric acid level in normal pregnant and preeclamptic ladies: a comparative study. Nepal Med Coll J 2014; 16(1):30-2.

Nischintha S, Pallavee P, Ghose S. Correlation between 24-h urine protein, spot urine protein/creatinine ratio, and serum uric acid and their association with fetomaternal outcomes in preeclamptic women. J Natural Sci Biol Med. 2014;5(2):255.

Kim SM, Park JS, Norwitz ER, Jung HJ, Kim BJ, Park CW, et al. Circulating levels of neutrophil gelatinase-associated lipocalin (NGAL) correlate with the presence and severity of preeclampsia. Reprod Sci. 2013;20(9):1083-9.

Dogan N1, Yildirmaki S, Mihmanli V, Vardar M, Ozbanazi YG, Cakmak M, et al. Serum neutrophil gelatinase associated lipocalin and plasma nitric oxide levels in healthy and preeclamptic pregnants. Clin Exp Obstet Gynecol. 2014;41(6):700-3.